The 2024 FPM Annual Symposium– Pharmaceutical medicine: tackling global challenges– will explore how health systems around the world must adapt as chronic physical and mental health issues become more prevalent, reflecting upon pharmaceutical medicine’s vital role in understanding impacts and developing mitigations.
Find out more about our inspiring speakers below.
Founder of Race in STEM (part of BioTalent)
A dynamic and open-minded thought leader, Steve is a passionate speaker, mentor, and advocate in the D&I space, where he cultivates ideas, challenges companies on how to diversify their workforce, and builds meaningful connections with a range of communities.
Steve is the Founder of Race in STEM (part of BioTalent) which seeks to encourage, question and inspire people of different cultural backgrounds and ethnicities in the world of STEM.
Professor of Infection and Inequities at Queen Mary University of London and Consultant Physician at Barts Health NHS Trust.
She specialises in therapeutics and has contributed to the licensing of medicines for HIV, viral hepatitis, and SARS-CoV-2. She is the global lead author for the first-ever long-acting injectable HIV therapy.
Chloe is an expert advisor to WHO Europe on mpox and COVID-19. During the multi-country mpox (monkeypox) outbreaks she established and led an international collaborative clinical network (SHARE-net) resulting in three global case series on mpox infection.
She is the Academic Lead for Equality Diversity and Inclusion in the Faculty of Medicine at QMUL. She directs the QMUL-based SHARE research collaborative for health equity.
Chloe is the 80th President of the Medical Women’s Federation, past Chair of the British HIV Association, on the governing council for the International AIDS Society and a scientific advisor to the Medicines Patent Pool.
Area Medical Director Middle East and Africa AstraZeneca
Currently working as Area Medical Director Middle East and Africa AstraZeneca driving medical strategy across all therapy areas in the area as well as develop medical talents. Previously was the International (Emerging markets) Oncology Medical Director preceded by Medical Director- Malaysia, Singapore, Brunei across all therapy areas. Before that, lead the Diabetes portfolio in AstraZeneca for Asia area. Experience as a pharmaceutical physician for 20 years across Emerging countries in primary and leadership positions. Diverse therapeutic area experience in oncology, infectious diseases, cardiology, ophthalmology, allergy, diabetes and pediatrics. Has had experience of Clinical Research managing Phase 2 and 3 clinical trials. Before joining industry, has had experience of working on clinical studies in cardiology.
Viraj is also the recipient of the Gufic prize for best original paper on Herbal research, Indian Pharmacological society annual conference, 2000.
Chief Medical Officer at Prilenia
Dr Jina Swartz is an accomplished physician and researcher who holds degrees in Internal Medicine and Neurology obtained in South Africa, as well as a PhD from the University of Cambridge. In 2020 she was elected to the Fellowship of the Academy of Medical Sciences for her global expertise in neurodegenerative disorders and neuropsychiatric drug development. With over thirty years in industry and academic Neurology, she specialises in both common and rare neurological diseases. Currently serving as Chief Medical Officer at Prilenia, she leads efforts in developing treatments for Huntington’s disease and other neurodegenerative disorders. Previously, she held leadership roles at Exciva and Merck and Co. She contributes extensively to charitable organisations and academic initiatives, focusing on health of internally displaced populations and refugees and neurology research.
Frank Gray
Dr Susan Hodgson
Dr Maria Orr
Dr John Porter
Dr Kailash Swarna
